Buckley Robert

CFO Buckley sells 9,957 shares at $116.77 blended average; stock now at $119.33, but down 18.5% from 52-week high

Robert Buckley, Chief Financial Officer, executed 4 separate sales totaling 9,957 shares for $1,162,651.44 on March 16, 2026, at prices ranging from $116.02 to $118.80, reducing his holdings by 9.3% to 96,616 shares. His prior trades at NOVT show a consistent pattern: all 5 prior sells were well-timed at the 90-day mark, with negative returns ranging from -3.0% to -18.5%, suggesting he has successfully anticipated downturns at this specific ticker. The current stock price of $119.33 sits 18.5% below the 52-week high of $146.39, which he sold into during the peak-to-trough decline. However, the company's high P/E of 100.28 and limited net income of $10.7M on $247.8M revenue raise fundamental questions about valuation sustainability that warrant attention to post-transaction performance.

CFO Buckley sells 3,660 shares at blended $180.38; stock at $182.65 near 52-week high of $186.20.

Buckley Robert, Chief Financial Officer of Novanta Inc, executed 2 separate sales totaling 3,660 shares on 2024-11-06 for a combined proceeds of $660,184.40 at a blended average price of $180.38. The transaction reduces his holdings by 2.9% to 120,419 shares post-sale. The stock is currently trading at $182.65, within 1.9% of its 52-week high of $186.20 and up 4.4% over the past 30 days. His prior cross-ticker sales history shows a 33.33% well-timed rate at the 90-day horizon, though measurable outcomes are not yet available for his five prior trades at Novanta executed on 2024-11-01. At a P/E of 109.37 against quarterly revenue of $244,405,000.00 and net income of $19,192,000.00, the stock is priced at a significant premium; this moderate-sized CFO sale near all-time highs warrants tracking to understand whether it signals reassessment at current valuation levels or is routine portfolio activity.

CFO Buckley sells 3,660 NOVT shares across 5 tranches (Nov 1) at blended avg $173.10; current price $164.67, down 5.9% in 30d.

Robert Buckley, Chief Financial Officer of Novanta Inc, executed 5 separate sales totaling 3,660 shares for $633,563.88 on November 1, 2024, at prices ranging from $170.78 to $174.59 and a blended average of $173.10. The stock has declined 5.9% over the past 30 days and now trades at $164.67, which is 11.6% below its 52-week high, suggesting the sales occurred near a recent peak. At Novanta specifically, Buckley's prior 5 trades (all sells on October 1) showed negative 30-day returns ranging from -1.6% to -3.9%, indicating a pattern of selling ahead of downward price movement at this ticker. His cross-ticker track record shows a 25.00% well-timed rate across 20 prior sells, though the company's elevated P/E of 98.60 against modest 2.4% annual revenue growth may reflect valuation constraints that merit investor attention.

CFO Buckley sells 3,660 shares ($636.9K) at $174.01 avg on NOVT; post-sale holds 120.4K shares

Robert Buckley, CFO of Novanta Inc, executed 5 separate sales totaling 3,660 shares for $636,886.04 on 2024-10-01 at an average price of $174.01. This represents a -2.9% reduction from his pre-transaction holdings of 124.1K shares, leaving him with 120.4K shares post-transaction. His recent prior sales at NOVT on 2024-09-03 showed negative 30-day returns (ranging from -1.5% to -5.4%), and his cross-ticker track record shows sells with an average 90-day return of -3.1%. The current stock price of $171.84 is -7.7% from the 52-week high of $186.20, suggesting the stock has since declined slightly from his transaction price, though broader context of his execution timing across multiple price points within the same day (ranging from $173.00 to $177.23) suggests a staged liquidation rather than a single-point decision.

CFO Robert Buckley sells 4,379 shares of NOVT for $771,582.00 at blended avg $176.20

On 2024-09-03, CFO Robert Buckley executed 7 separate sales totaling 4,379 shares (4.4K shares) for $771,582.00, reducing his holdings by 3.5% to 120,419 shares. The blended average transaction price of $176.20 sits 2.1% above the current price of $172.69 and 5.4% below the 52-week high of $186.20, placing this sale near—but not at—peak valuation. His cross-ticker track record shows 19 prior sells with an average 90-day return of 3.0%, indicating prior sales have been poorly timed (stock rose after); however, prior trades at NOVT in August 2024 showed 30-day returns ranging from 1.3% to 8.6%. The modest share reduction and placement within the upper half of the 52-week range, combined with his mixed historical timing, provide limited directional signal for investors.

CFO Robert Buckley sold 4,108 shares of NOVT at blended average $172.75, realizing $709.7K; stock now trading at $156.50 (-9.4% vs transaction prices).

Robert Buckley, Chief Financial Officer of Novanta, executed 10 separate sales totaling 4,108 shares for $709,671.85 on 2024-08-01, at prices ranging from $168.79 to $180.94 (blended average $172.75), reducing his holdings by 3.3% from 124,527 to 120,419 shares. The current stock price of $156.50 sits at -16.0% from the 52-week high of $186.20 and has declined 1.8% over 30 days and 3.3% over 90 days since the transaction. At Novanta specifically, Buckley's prior 5 trades show 3 of 5 were well-timed at the 90-day mark (negative post-sale returns), though his broader cross-ticker sell history (9 prior sales) averaged only a 33.33% well-timed rate with a +3.0% average 90-day return—suggesting his sells have historically missed upside. The company trades at a notably elevated P/E of 81.09 despite modest 2.4% annual revenue growth, and the filing itself reflects no scheduled plan flagging that could explain the multi-tranche structure.